SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Janssen Research & Development, LLC Release: FDA Grants Priority Review to Bedaquiline (TMC207) for Multi-Drug Resistant Tuberculosis Treatment